Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.50
Bid: 3.25
Ask: 3.75
Change: 0.00 (0.00%)
Spread: 0.50 (15.385%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.50
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: 888 advances US exit; Arrow ups reserve estimate

Thu, 28th Mar 2024 14:35

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Critical Metals PLC - DRC-focused mining company - Posts pretax loss of GBP1.1 million in the six months ended December 31, narrowed from GBP1.3 million a year before. Losses before interest, tax, depreciation and amortisation also narrows to GBP1.1 million from GBP1.3 million. Losses per share trimmed to 1.59 pence from 2.67p a year prior. Says is focussing on advancing its Molulu copper-cobalt asset in the DRC, in which it holds a 70% interest.

----------

Global Petroleum Ltd - Africa and Mediterranean-focused oil and gas company - Delivers a pretax loss of just USD3,164 in the six months to December 31, narrowed from a loss of USD695,619 a year prior. Says the first half loss reflects ongoing exploration expenditure in Namibia, where the company is focusing on securing a farm-out agreement for its PEL0094 licence. Says income was USD305,799 for the period, up from no income in the latter half of 2022. As at December 31, Global Petroleum's cash balance was USD597,365, up from USD356,389.

----------

888 Holdings PLC - Gibraltar-headquartered sports betting and gambling company, which owns brands including 888casino and William Hill - Agrees to sell selected US B2C assets to Hard Rock Digital. Earlier in March, 888 said it was contemplating disposing of its US operations, and says it intends to do so by the end of 2024. Its US exit will realise an annual adjusted earnings before interest, tax, depreciation and amortisation benefit of GBP25 million from 2025 onwards, but adds that the sale of its US assets will incur one-off costs of GBP40 million. On Tuesday, 888 said it was planning to change its name to Evoke PLC, subject to shareholder approval at its 2024 annual general meeting, to "better reflect the strength of the group's multi-brand operating model".

----------

Iconic Labs PLC - London-based media and technology company - Reports no revenue in the six months ended December 31, unchanged from a year before. Pretax profit sank to GBP270,131 from GBP5.5 million, which Iconic says reflects "the writing back of creditors balances which are no longer due and the creditor settlements under the [company voluntary arrangement]", which it exited in October. Iconic says its focus is now on "acquiring a suitable company through a reverse takeover". Iconic has signed a heads of terms deal with the owners of ITS Holdings 2023 Ltd, to acquire Style Fashion Ltd, though adds that no binding agreement has been reached. Says the deal meets its "strategic objectives of long-term growth and value for our shareholders."

----------

India Capital Growth Fund Ltd - closed-ended investment firm focused on Indian companies - Net asset value per share increases 29% to 180.11p from 140.06p in 2023, underperforming the company's benchmark S&P Midcap Total Return Index's 38%. Looking ahead, says there is a "broad consensus" that Indian gross domestic product will grow 6% to 7% per annum for the next few years, adding that its economy demonstrates "a favourable regulatory environment, improved infrastructure, healthy corporate balance sheets and policies geared towards investment led development". Says that while India's previous growth has been largely consumption-led, the next phase of growth will be driven by investments.

----------

Arrow Exploration Corp - Calgary, Canada-based oil and gas company focused on Colombian and Canadian projects - Confirms sharp increases in the net present value of its 1P reserves and 2P reserves. Says 1P reserve estimates increased 57% to 5.29 million barrels of oil equivalent, thanks to the discovery of the Carrizales Norte field and successful drilling at the Rio Crave Este field, both in Colombia. the NPV of its 1P reserves, discounted 10%, is USD134.88 million. 2P reserve estimates increased by 54% to 11.8 million boe, with a NPV-10 of USD280.22 million. 3P reserve estimates increased 53% to 17.8 million boe, with an NPV of USD445.02 million.

----------

Microlise Group PLC - Nottingham-based software as a service technology provider - Signs 5-year contract worth a total of AUD20 million, GBP10.3 million, with WooliesX, part of the Australian supermarket chain Woolworths Group Ltd. Says it will deploy its solutions to optimise WooliesX's home delivery operations. Roll-out of its services has already begun, with the remainder taking place in 2024, Microlise says.

----------

Genedrive PLC - Manchester-based molecular diagnostics company - Delivers GBP238,000 in revenue in the six months to December 31, up from GBP21,000 a year before. Pretax loss narrows to GBP2.0 million from GBP2.2 million. Basic loss per share narrows to 2.0p from 2.4p. Company adds that it is in "advanced" negotiations with a US-based medical group to support a clinical trial pathway for its MT-RNR1 pharmacogenetic test.

----------

By Hugh Cameron, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
28 Jan 2020 16:06

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
3 Dec 2019 10:10

Genedrive Antibiotic Induced Hearing Loss Test Kit Shows High Accuracy

Genedrive Antibiotic Induced Hearing Loss Test Kit Shows High Accuracy

Read more
3 Dec 2019 09:39

Genedrive upbeat on latest results from RNR1 kit testing

(Sharecast News) - Near-patient molecular diagnostics company Genedrive announced on Tuesday that in its case-control clinical validation, the antibiotic-induced hearing loss assay - the 'Genedrive MT-RNR1 ID' kit - achieved a diagnostic sensitivity of 100% and specificity of 100% on a cohort of 303 samples.

Read more
18 Nov 2019 16:00

Genedrive infant hearing loss test gets CE mark

(Sharecast News) - Molecular diagnostics company Genedrive announced on Monday that its antibiotic-induced hearing loss test, the 'Genedrive MT-RNR1 ID' kit, has obtained CE marking.

Read more
18 Nov 2019 11:15

Genedrive's Antibiotic Induced Hearing Loss Assay Receives CE Marking

Genedrive's Antibiotic Induced Hearing Loss Assay Receives CE Marking

Read more
7 Oct 2019 11:59

NHS Ethics Approval Granted For Genedrive MT-RNR1 Screening Test Trial

NHS Ethics Approval Granted For Genedrive MT-RNR1 Screening Test Trial

Read more
3 Oct 2019 11:00

Genedrive Outlook Positive As Revenue Up And Loss Narrows In Full Year

Genedrive Outlook Positive As Revenue Up And Loss Narrows In Full Year

Read more
3 Oct 2019 10:41

Genedrive loss narrowed after double-digit revenue rise

(Sharecast News) - Genedrive on Thursday reported a narrowed annual loss as revenues jumped as its commercial relationship with the US department of defense (DoD) exceeded expectations.

Read more
9 Jul 2019 10:54

Genedrive Revenue To Suffer On Lower Uptake Of Hepatitis Test Kits

(Alliance News) - Shares in Genedrive PLC fell Tuesday after the company warned that it will miss market expectations for 2020 financial year revenue due to slower than expected uptake of the HCV

Read more
28 Mar 2019 10:36

Genedrive Interim Loss Narrows As It Continues Focus On Hepatitis

LONDON (Alliance News) - Genedrive PLC on Thursday reported a reduction in its interim loss, as it continues to progress its hepatitis testing product.For the six months to the end of 2018,

Read more
28 Mar 2019 07:59

Genedrive losses narrow despite increased R&D costs

(Sharecast News) - Molecular diagnostics company Genedrive saw revenues tick ahead slightly in the first half of its financial year but increased research and development costs kept the firm in the red.

Read more
15 Jan 2019 12:44

Genedrive Interim Revenue Rises On US And UK Government Contracts

LONDON (Alliance News) - Genedrive PLC said Tuesday it increased its first-half income and made "good progress" on two UK government funded projects.For the six months to the end

Read more
15 Jan 2019 10:17

Genedrive makes progress with HCV kit in first half

(Sharecast News) - Near-patient molecular diagnostics company Genedrive issued an unaudited update for the six months ended 31 December on Tuesday, reporting revenue of £1.5m, up from £1.3m year-on-year.

Read more
10 Dec 2018 16:23

BGF Investment Management Now Owns 12.8% Stake In Genedrive (ALLISS)

LONDON (Alliance News) - Genedrive PLC said Monday that BGF Investment Management Ltd now owns a 12.8% stake in the company.BGF's stake in the firm prior to Monday's deal, if any,

Read more
29 Nov 2018 13:56

Genedrive To Participate In Study For Use Of HCV Assay In Pharmacies

LONDON (Alliance News) - Genedrive PLC on Thursday said it will participate in an international multicentre trial to assess the impact of out-reach HCV diagnostics and therapy in a pharmacy versus

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.